Symphony Technology sells AlphaImpactRx to IMS Health

Symphony Technology Group sold its portfolio company AlphaImpactRx to IMS Health. Terms of the transaction were not disclosed. Symphony created AlphaImpactRx, a provider of research-based insights to biopharmaceutical and consumer health companies, in 2011 through the combination of three biopharmaceutical companies.

DealsNorth AmericaUSBriefs